Dr. William R. Wise , MD
Urology • Las Vegas, NV
7200 Cathedral Rock Dr., Suite 180
Las Vegas, NV 891280466
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 4, 2006; this date does not establish years in practice.
-
Published CMS data list 1,854 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 467 service units.
- 81003 — Automated urinalysis test: 269 service units.
- 52000 — Diagnostic exam of bladder and urethra using an endoscope: 161 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 24 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,486 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 827 prescription fills, including refills.
- Ciprofloxacin Hcl — 303 prescription fills, including refills.
- Solifenacin Succinate — 294 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Urology in Las Vegas, NV (2024, 18 clinicians with data). Median for this group: 2,110. Middle half: 1,684 to 3,726.
Close to the middle for Medicare Part B services among clinicians listed under Urology in Nevada (2024, 48 clinicians with data). Median for this group: 1,753. Middle half: 474 to 3,018.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,215 in 2020 to 1,854 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
7200 Cathedral Rock Dr.
Suite 180
Las Vegas, NV 891280466
CMS Doctors and Clinicians lists 1 group name: Las Vegas Urology Llp. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Creighton University School Of Medicine
1982
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
631 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $198,422 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $149,901 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
5,352 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$364,054 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,103.78 across 67 records.
By nature of payment
- Food and Beverage: $2,103.78 across 67 records.
Reporting-company totals (3 largest of 22)
- Procept Biorobotics Corporation: $426.59 across 5 records.
- Astellas Pharma US Inc: $239.96 across 9 records.
- Janssen Pharmaceuticals, Inc: $192.53 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
44 years (graduated 1982)
CMS Doctors and Clinicians data list 1982 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Wise has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Wise as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Las Vegas and Nevada
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Urology in Las Vegas, NV (2024, 18 clinicians with data). Median for this group: 2,110. Middle half: 1,684 to 3,726.
Close to the middle for clinicians listed under Urology in Nevada (2024, 48 clinicians with data). Median for this group: 1,753. Middle half: 474 to 3,018.
Medicare-allowed amount
Close to the middle for clinicians listed under Urology in Las Vegas, NV (2024, 18 clinicians with data). Median for this group: $190,569. Middle half: $124,480 to $375,704.
A higher Medicare-allowed amount than 70% of clinicians listed under Urology in Nevada (2024, 48 clinicians with data). Median for this group: $153,697. Middle half: $53,827 to $201,388.
Paid by Medicare
Close to the middle for clinicians listed under Urology in Las Vegas, NV (2024, 18 clinicians with data). Median for this group: $143,691. Middle half: $92,171 to $287,198.
A higher Medicare payment amount than 70% of clinicians listed under Urology in Nevada (2024, 48 clinicians with data). Median for this group: $114,175. Middle half: $37,590 to $151,799.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Urology in Las Vegas, NV (2024, 18 clinicians with data). Median for this group: 1,326. Middle half: 1,037 to 1,601.
More Part D prescriptions than 85% of clinicians listed under Urology in Nevada (2024, 51 clinicians with data). Median for this group: 1,003. Middle half: 306 to 1,601.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Urology in Las Vegas, NV (2024, 18 clinicians with data). Median for this group: $169,328. Middle half: $116,041 to $344,581.
A higher Part D drug cost than 80% of clinicians listed under Urology in Nevada (2024, 51 clinicians with data). Median for this group: $113,206. Middle half: $20,660 to $320,878.
28 active clinicians are listed under Urology with a practice address in Las Vegas, NV (75 in Nevada).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Las Vegas
35.7% of these 28 clinicians have the CMS telehealth indicator.
64.3% of these 28 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 16% from 2,215 in 2020 to 1,854 in 2024.
- 2020: 2,215
- 2021: 1,777
- 2022: 2,377
- 2023: 1,998
- 2024: 1,854
-
Medicare-allowed amount
Medicare-allowed amount decreased 10% from $219,575 in 2020 to $198,422 in 2024.
- 2020: $219,575
- 2021: $197,113
- 2022: $234,541
- 2023: $239,131
- 2024: $198,422
-
Paid by Medicare
Paid by Medicare stayed about the same: $164,481 in 2020 and $149,901 in 2024.
- 2020: $164,481
- 2021: $148,616
- 2022: $177,576
- 2023: $180,557
- 2024: $149,901
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 2,304 in 2020 and 2,486 in 2024.
- 2020: 2,304
- 2021: 1,968
- 2022: 2,240
- 2023: 2,405
- 2024: 2,486
-
30-day fills
30-day fills increased 12% from 4,765 in 2020 to 5,352 in 2024.
- 2020: 4,765
- 2021: 4,060
- 2022: 4,852
- 2023: 5,081
- 2024: 5,352
-
Part D drug cost
Part D drug cost increased 168% from $135,772 in 2020 to $364,054 in 2024.
- 2020: $135,772
- 2021: $65,444
- 2022: $83,217
- 2023: $86,650
- 2024: $364,054
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $973.76 in 2021 to $2,103.78 in 2025.
- 2021: $973.76
- 2022: $1,410.72
- 2023: $1,565.76
- 2024: $2,218.67
- 2025: $2,103.78
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 67 records totaling $2,103.78.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $161.66 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $160.47 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $142.69 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Moses | General | $112.43 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $58.93 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
SOLESTA | General | $41.08 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $35.71 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $34.88 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.95 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Padcev | General | $33.39 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.23 |
| Blue Earth Diagnostics |
Food and Beverage
In-kind items and services
|
POSLUMA | General | $32.78 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $32.68 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $32.43 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $30.92 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
ZUSDURI | General | $30.70 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Padcev | General | $30.31 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $30.17 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $29.80 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $29.49 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $29.24 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
LithoVue | General | $28.88 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $28.79 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $27.89 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $27.88 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
467 | 327 | $251.93 | $124.79 |
|
81003
Automated urinalysis test
|
269 | 198 | $4.00 | $2.19 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
161 | 141 | $471.48 | $235.49 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
160 | 138 | $178.28 | $89.31 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
152 | 119 | $22.00 | $11.09 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
103 | 103 | $327.55 | $163.78 |
|
81002
Urinalysis, manual test
|
94 | 84 | $7.00 | $3.41 |
|
88112
Cell examination of specimen, selective cellular enhancement technique
|
64 | 60 | $133.34 | $40.09 |
|
51700
Simple bladder irrigation and/or instillation
|
49 | 36 | $150.41 | $74.44 |
|
96372
Injection of drug or substance under skin or into muscle
|
40 | 16 | $28.23 | $14.07 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
34 | 33 | $252.59 | $126.48 |
|
76942
Ultrasonic guidance for needle placement
|
30 | 29 | $114.13 | $53.28 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
30 | 15 | $5.00 | $2.60 |
|
55700
Biopsy of prostate gland
|
29 | 29 | $470.72 | $223.80 |
|
76872
Ultrasound scan of pelvic region through rectum
|
29 | 29 | $395.48 | $128.02 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
22 | 21 | $126.36 | $31.55 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
19 | 19 | $715.26 | $357.83 |
|
51741
Electronic assessment of bladder emptying
|
19 | 19 | $28.16 | $7.36 |
|
52356
Crushing of stone of ureter with insertion of stent using an endoscope
|
16 | 16 | $792.00 | $397.83 |
|
52310
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope
|
15 | 15 | $625.73 | $312.82 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
14 | 14 | $218.64 | $109.54 |
|
53854
Destruction of prostate tissue using radiofrequency induced heated water vapor
|
13 | 13 | $3285.08 | $1625.78 |
|
G0416
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method
|
13 | 13 | $712.00 | $202.19 |
|
52332
Insertion of stent in ureter using an endoscope
|
12 | 12 | $391.08 | $127.83 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 827 | 68,624 | $10,100.11 | 374 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 303 | 1,991 | $1,402.92 | 262 |
| Solifenacin Succinate | Solifenacin Succinate | 294 | 23,166 | $10,537.36 | 156 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 165 | 1,140 | $1,262.87 | 154 |
| Finasteride | Finasteride | 105 | 8,690 | $1,107.78 | 46 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 93 | 7,985 | $1,969.01 | 49 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 87 | 870 | $1,276.50 | 72 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 75 | 5,920 | $2,976.20 | 47 |
| Oxybutynin Chloride | Oxybutynin Chloride | 68 | 5,670 | $784.51 | 35 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 55 | 394 | $341.96 | 51 |
| Myrbetriq | Mirabegron | 50 | 2,910 | $42,477.42 | 16 |
| Fluconazole | Fluconazole | 45 | 138 | $92.02 | 27 |
| Sildenafil Citrate | Sildenafil Citrate | 40 | 1,281 | $200.11 | 14 |
| Desmopressin Acetate | Desmopressin Acetate | 38 | 1,545 | $2,409.88 | 11 |
| Gemtesa | Vibegron | 35 | 2,687 | $42,069.98 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 34 | 1,711 | $1,926.63 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 986 | $99.23 | 23 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | 1,290 | $238.69 | — |
| Cephalexin | Cephalexin | 18 | 1,174 | $236.21 | — |
| Xtandi | Enzalutamide | 17 | 510 | $237,491.96 | — |
| Testosterone | Testosterone | 14 | 950 | $3,910.53 | — |
| Allopurinol | Allopurinol | 13 | 1,050 | $70.30 | — |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | 194 | $59.97 | — |
| Potassium Citrate Er | Potassium Citrate | 13 | 620 | $739.52 | — |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | 1,080 | $153.61 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20050409000018
NV
2264479476
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Las Vegas Urology Llp
7500 Smoke Ranch Rd, Las Vegas, NV 891280373
Phone: 7022330727
Las Vegas Urology Llp
7501 Trinity Peak Ave, Las Vegas, NV 891289026
Phone: 7028038874
Las Vegas Urology Llp
2310 Corporate Cir, Henderson, NV 890747729
Phone: 7027358000
Las Vegas Urology Llp
1701 N Green Valley Pkwy, Henderson, NV 890745885
Phone: 7028969600
Las Vegas Urology Llp
7150 W Sunset Rd, Las Vegas, NV 891131982
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History
NPI enumerated October 04, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Las Vegas
- Dr. Mulugeta Kassahun, MD
- Dr. Ilya Gorbachinsky, MD
- Dr. Ranjit Jain, MD
- Dr. Avi Weiss, MD
- Dr. Andrew Grudzinski, MD
- Dr. David Miller, MD
Mailing Address
7150 W Sunset Rd, Suite 201a
Las Vegas, NV 891131981
Phone: 7023854342